Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

2,604 public trials 495 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Active, Not Recruiting

MInimal Residual Disease Adapted Strategy

NCT04934475

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Institut Jules Bordet Brussels, Belgium
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • Grand Hôpital de Charleroi - Site de Notre-Dame Charleroi, Belgium
  • Hôpital Jolimont Haine-Saint-Paul, Belgium
View all 73 locations
View Trial Details
Active, Not Recruiting

Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refractory Multiple Myeloma

NCT04756401

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • State University of New York Upstate Medical University Syracuse, New York, United States
  • UNC Lineberger Comprehensive Cancer Center University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • Carolinas Medical Center/Levine Cancer Institute Charlotte, North Carolina, United States
View Trial Details
Active, Not Recruiting

Ixazomib in the Prophylaxis of Chronic Graft-versus-host Disease.

NCT03225417

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • ICO- Hospital Germans Trias i Pujol Badalona, Spain
  • Hospital Clinic de Barcelona Barcelona, Spain
  • Hospital de la Santa Creu I Sant Pau Barcelona, Spain
  • Hospital Universitario Vall D´Hebrón Barcelona, Spain
View Trial Details
Active, Not Recruiting

Cytogenetic Studies in Acute Leukemia and Multiple Myeloma

NCT00048958

Conditions
Acute Leukemia, Acute Lymphoblastic Leukemia, Blood Protein Disorders, +21 more
Locations
  • Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States
  • Camino Medical Group - Treatment Center Mountain View, California, United States
  • Kaiser Permanente Medical Office -Vandever Medical Office San Diego, California, United States
  • Naval Medical Center - San Diego San Diego, California, United States
View all 137 locations
View Trial Details
Active, Not Recruiting

Clinical Trial to Evaluate Zevor-cel (CT053) in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 2)

NCT03915184

Conditions
Blood Protein Disorders, Carcinoma, Cardiovascular Diseases, +14 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • UCSF San Francisco, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

Safety, Activity and Cell Kinetics of CYAD-211 in Patients With Relapsed or Refractory Multiple Myeloma

NCT04613557

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • Nyu Langone Hospitals New York, United States
  • Universitair Ziekenhuis Antwerpen Antwerp, Belgium
  • Institut Jules Bordet Brussels, Belgium
View Trial Details

Related conditions